MiFID II Readiness: The Final Countdown
With just under two months to go before MiFID II is officially implemented, Laura Glynn, Fenergo director of regulatory compliance, reviews the impact that this wide-ranging regulation is set to have on client onboarding and lifecycle management processes for banks in Europe and all over the world.
Initially scheduled for implementation on January 3rd, 2017, the Markets in Financial Instruments Directive (MiFID) II was specifically delayed based on industry feedback regarding the exceptional technical implementation challenges that it poses for regulators and market participants alike.
With the EU commission recently ruling out any further extensions of the MiFID II deadline, it’s perhaps the best time to review the key changes and impacts that this wide-ranging regulation will impose on global financial institutions once more. In the case of asset managers, MiFID II readiness has been slightly pushed back towards Q4 2017 or early 2018, b
MiFID II compliance requires preparation
Financial services providers better be prepared for additional scrutiny under MiFID II, Laura Glynn advises.
Ms. Glynn is the global regulatory affairs manager with Fenergo, a provider of client lifecycle management software solutions for investment, corporate and private banks. Fenergo’s solutions help institutions manage the end-to-end regulatory onboarding and entity data management processes. They are rules-driven to ensure compliance with multiple regulatory frameworks while supporting the collection, centralization and sharing of client and counterparty data and documentation institution-wide.
The United Kingdom’s Financial Conduct Authority provides the following definition of MiFID II on its website:
UCI-led team awarded $2 3 million as part of the California Initiative to Advance Precision Medicine uci.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uci.edu Daily Mail and Mail on Sunday newspapers.
UCI-led team to address health impacts of adverse childhood experiences using precision medicine
A collaborative team centered in the University of California, Irvine (UCI) and including Children s Hospital Orange County (CHOC) and Chapman University (CU) has been awarded a three-year grant totaling in excess of $2.3 million, to address the health impacts of adverse childhood experiences (ACEs) using precision medicine. Announced by the California Governor s Office of Planning & Research, in partnership with the Office of the California Surgeon General, the award is part of the California Initiative to Advance Precision Medicine (CIAPM). The research project will begin May 2021.
Led by Tallie Z. Baram, MD, PhD, Bren Distinguished Professor and director of the Conte Center at UCI, the UCI, CHOC and CU team has established two goals. The first is to identify the degree to which unpredictability of early life experiences interacts with established ACEs to influence children s neurodev
E-Mail
IMAGE: Outcomes of infants are modulated by genetic origins as well as by early-life experiences. Comparing saliva DNA of a child, at birth and again at one year of age,. view more
Credit: UCI School of Medicine
Irvine, CA - April 1, 2021 - A collaborative team centered in the University of California, Irvine (UCI) and including Children s Hospital Orange County (CHOC) and Chapman University (CU) has been awarded a three-year grant totaling in excess of $2.3 million, to address the health impacts of adverse childhood experiences (ACEs) using precision medicine. Announced by the California Governor s Office of Planning & Research, in partnership with the Office of the California Surgeon General, the award is part of the California Initiative to Advance Precision Medicine (CIAPM). The research project will begin May 2021.